{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:01:35Z","timestamp":1790092895136,"version":"4.0.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"DOI":"10.1007\/s11606-026-10830-8","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:10:24Z","timestamp":1790089824000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Extremely High NT-proBNP in Unselected Hospital Admissions: A Retrospective Analysis of Diagnoses and Outcomes"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0727-2717","authenticated-orcid":false,"given":"Amro","family":"Abu Suleiman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Bhatty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian D.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Desborough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew L.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"10830_CR1","doi-asserted-by":"publisher","unstructured":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. https:\/\/doi.org\/10.1093\/eurheartj\/ehab368.","DOI":"10.1093\/eurheartj\/ehab368"},{"key":"10830_CR2","unstructured":"Chronic heart failure in adults: diagnosis and management NICE guideline. Published online 2018. www.nice.org.uk\/guidance\/ng106. Accessed 27 May 2025."},{"issue":"18","key":"10830_CR3","doi-asserted-by":"publisher","first-page":"E895","DOI":"10.1161\/CIR.0000000000001063;PAGE:STRING:ARTICLE\/CHAPTER","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):E895-E1032. https:\/\/doi.org\/10.1161\/CIR.0000000000001063;PAGE:STRING:ARTICLE\/CHAPTER.","journal-title":"Circulation."},{"issue":"8","key":"10830_CR4","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1097\/01.CCM.0000229144.97624.90","volume":"34","author":"A Rudiger","year":"2006","unstructured":"Rudiger A, Gasser S, Fischler M, Hornemann T, Von Eckardstein A, Maggiorini M. Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure. Crit Care Med. 2006;34(8):2140-2144. https:\/\/doi.org\/10.1097\/01.CCM.0000229144.97624.90.","journal-title":"Crit Care Med."},{"issue":"4","key":"10830_CR5","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/J.JJCC.2021.05.003\/ASSET\/F7FF6C52-0C68-4673-8681-F89EE0E06FE3\/MAIN.ASSETS\/GR4.JPG","volume":"78","author":"T Nishikimi","year":"2021","unstructured":"Nishikimi T, Nakagawa Y. Potential pitfalls when interpreting plasma BNP levels in heart failure practice. J Cardiol. 2021;78(4):269-274. https:\/\/doi.org\/10.1016\/J.JJCC.2021.05.003\/ASSET\/F7FF6C52-0C68-4673-8681-F89EE0E06FE3\/MAIN.ASSETS\/GR4.JPG.","journal-title":"J Cardiol."},{"issue":"9","key":"10830_CR6","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/J.EJHEART.2008.07.014","volume":"10","author":"A Maisel","year":"2008","unstructured":"Maisel A, Mueller C, Adams K, et al. State of the art: Using natriuretic peptide levels in clinical practice. Eur J Heart Fail. 2008;10(9):824-839. https:\/\/doi.org\/10.1016\/J.EJHEART.2008.07.014.","journal-title":"Eur J Heart Fail."},{"key":"10830_CR7","doi-asserted-by":"publisher","unstructured":"Sato R, Nasu M. A review of sepsis-induced cardiomyopathy. J Intensive Care 2015 3:1. 2015;3(1):48-. https:\/\/doi.org\/10.1186\/S40560-015-0112-5.","DOI":"10.1186\/S40560-015-0112-5"},{"key":"10830_CR8","doi-asserted-by":"publisher","first-page":"1293866","DOI":"10.3389\/FCVM.2023.1293866","volume":"10","author":"Y Zhai","year":"2023","unstructured":"Zhai Y, Yao Q, The E, Ao L, Fullerton DA, Meng X. Aging exacerbates cardiac dysfunction and mortality in sepsis through enhancing TLR2 activity. Front Cardiovasc Med. 2023;10:1293866. https:\/\/doi.org\/10.3389\/FCVM.2023.1293866.","journal-title":"Front Cardiovasc Med."},{"key":"10830_CR9","doi-asserted-by":"publisher","unstructured":"Doody P, Asamane EA, Aunger JA, et al. The prevalence of frailty and pre-frailty among geriatric hospital inpatients and its association with economic prosperity and healthcare expenditure: A systematic review and meta-analysis of 467,779 geriatric hospital inpatients. Ageing Res Rev. 2022;80. https:\/\/doi.org\/10.1016\/j.arr.2022.101666.","DOI":"10.1016\/j.arr.2022.101666"},{"issue":"5","key":"10830_CR10","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1097\/01.CCM.0000162561.82012.E9","volume":"33","author":"A Roch","year":"2005","unstructured":"Roch A, Allardet-Servent J, Michelet P, et al. NH2 terminal pro-brain natriuretic peptide plasma level as an early marker of prognosis and cardiac dysfunction in septic shock patients. Crit Care Med. 2005;33(5):1001-1007. https:\/\/doi.org\/10.1097\/01.CCM.0000162561.82012.E9.","journal-title":"Crit Care Med."},{"issue":"4","key":"10830_CR11","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1161\/CIRCULATIONAHA.104.472050","volume":"112","author":"M Brueckmann","year":"2005","unstructured":"Brueckmann M, Huhle G, Lang S, et al. Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis. Circulation. 2005;112(4):527-534. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.104.472050.","journal-title":"Circulation."},{"key":"10830_CR12","doi-asserted-by":"publisher","unstructured":"Papanikolaou J, Makris D, Mpaka M, Palli E, Zygoulis P, Zakynthinos E. New insights into the mechanisms involved in B-type natriuretic peptide elevation and its prognostic value in septic patients. Crit Care. 2014;18(3). https:\/\/doi.org\/10.1186\/CC13864.","DOI":"10.1186\/CC13864"},{"issue":"1","key":"10830_CR13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/S10741-007-9002-9\/TABLES\/5","volume":"12","author":"MA Burke","year":"2007","unstructured":"Burke MA, Cotts WG. Interpretation of B-type natriuretic peptide in cardiac disease and other comorbid conditions. Heart Fail Rev. 2007;12(1):23-36. https:\/\/doi.org\/10.1007\/S10741-007-9002-9\/TABLES\/5.","journal-title":"Heart Fail Rev."},{"issue":"5","key":"10830_CR14","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1186\/CC2890","volume":"8","author":"R Witthaut","year":"2004","unstructured":"Witthaut R. Science review: Natriuretic peptides in critical illness. Crit Care. 2004;8(5):342. https:\/\/doi.org\/10.1186\/CC2890.","journal-title":"Crit Care."},{"key":"10830_CR15","doi-asserted-by":"publisher","unstructured":"Januzzi JL, Morss A, Tung R, et al. Natriuretic peptide testing for the evaluation of critically ill patients with shock in the intensive care unit: A prospective cohort study. Crit Care. 2006;10(1). https:\/\/doi.org\/10.1186\/CC4839.","DOI":"10.1186\/CC4839"},{"issue":"7","key":"10830_CR16","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.ejim.2007.01.006","volume":"18","author":"NI Nikolaou","year":"2007","unstructured":"Nikolaou NI, Goritsas C, Dede M, et al. Brain natriuretic peptide increases in septic patients without severe sepsis or shock. Eur J Intern Med. 2007;18(7):535-541. https:\/\/doi.org\/10.1016\/j.ejim.2007.01.006.","journal-title":"Eur J Intern Med."},{"issue":"5","key":"10830_CR17","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/MEJ.0B013E328332354B","volume":"17","author":"C Goritsas","year":"2010","unstructured":"Goritsas C, Fasoulaki M, Paissios NP, Giakoumaki E, Alamanos Y, Nikolaou NI. Brain natriuretic peptide plasma levels as a marker of prognosis in patients with community-acquired infection. European Journal of Emergency Medicine. 2010;17(5):293-295. https:\/\/doi.org\/10.1097\/MEJ.0B013E328332354B.","journal-title":"European Journal of Emergency Medicine."},{"issue":"4","key":"10830_CR18","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0828-282X(09)70066-2","volume":"25","author":"SL Bar","year":"2009","unstructured":"Bar SL, Sayeh N, Ignaszewski AP. Elevated N-terminal pro-brain natriuretic peptide in Mycobacterium tuberculosis pulmonary infection without myocardial dysfunction. Can J Cardiol. 2009;25(4):223-225. https:\/\/doi.org\/10.1016\/S0828-282X(09)70066-2.","journal-title":"Can J Cardiol."},{"issue":"9","key":"10830_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/JCM9092957","volume":"9","author":"S Sorrentino","year":"2020","unstructured":"Sorrentino S, Cacia M, Leo I, et al. B-type natriuretic peptide as biomarker of COVID-19 disease severity\u2014a meta-analysis. J Clin Med. 2020;9(9):1-7. https:\/\/doi.org\/10.3390\/JCM9092957.","journal-title":"J Clin Med."},{"issue":"9","key":"10830_CR20","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.amjcard.2011.12.026","volume":"109","author":"Y Al-Najjar","year":"2012","unstructured":"Al-Najjar Y, Clark AL. Predicting outcome in patients with left ventricular systolic chronic heart failure using a nutritional risk index. Am J Cardiol. 2012;109(9):1315-1320. https:\/\/doi.org\/10.1016\/j.amjcard.2011.12.026.","journal-title":"Am J Cardiol."},{"issue":"3","key":"10830_CR21","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/01.SLA.0000055547.93484.87","volume":"237","author":"JL Vincent","year":"2003","unstructured":"Vincent JL, Dubois MJ, Navickis RJ, Wilkes MM. Hypoalbuminemia in Acute Illness: Is There a Rationale for Intervention? A Meta-Analysis of Cohort Studies and Controlled Trials. Ann Surg. 2003;237(3):319. https:\/\/doi.org\/10.1097\/01.SLA.0000055547.93484.87.","journal-title":"Ann Surg."},{"key":"10830_CR22","doi-asserted-by":"publisher","first-page":"770674","DOI":"10.3389\/FNUT.2022.770674\/BIBTEX","volume":"9","author":"X Jin","year":"2022","unstructured":"Jin X, Li J, Sun L, et al. Prognostic Value of Serum Albumin Level in Critically Ill Patients: Observational Data From Large Intensive Care Unit Databases. Front Nutr. 2022;9:770674. https:\/\/doi.org\/10.3389\/FNUT.2022.770674\/BIBTEX.","journal-title":"Front Nutr."},{"issue":"1","key":"10830_CR23","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1001\/ARCHINTE.1992.00400130135017","volume":"152","author":"FR Herrmann","year":"1992","unstructured":"Herrmann FR, Safran C, Levkoff SE, Minaker KL. Serum Albumin Level on Admission as a Predictor of Death, Length of Stay, and Readmission. Arch Intern Med. 1992;152(1):125-130. https:\/\/doi.org\/10.1001\/ARCHINTE.1992.00400130135017.","journal-title":"Arch Intern Med."},{"key":"10830_CR24","unstructured":"Nehring SM, Goyal A, Bansal P, Patel BC. C-Reactive Protein: Clinical Relevance and Interpretation. StatPearls. 2025;65(5):237\u2013244. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK441843\/. Accessed 29 June 2025."},{"key":"10830_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/J.EJIM.2016.08.026","volume":"37","author":"A Ticinesi","year":"2017","unstructured":"Ticinesi A, Lauretani F, Nouvenne A, et al. C-reactive protein (CRP) measurement in geriatric patients hospitalized for acute infection. Eur J Intern Med. 2017;37:7-12. https:\/\/doi.org\/10.1016\/J.EJIM.2016.08.026.","journal-title":"Eur J Intern Med."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-026-10830-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-026-10830-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-026-10830-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:10:27Z","timestamp":1790089827000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-026-10830-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":25,"alternative-id":["10830"],"URL":"https:\/\/doi.org\/10.1007\/s11606-026-10830-8","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"assertion":[{"value":"26 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Hull University Teaching Hospitals NHS Trust institutional governance committee and classified as a retrospective service evaluation with waiver of individual consent.","order":1,"name":"Ethics","label":"Human Ethics and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author(s) declared no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Clinical Trial Number","group":{"name":"EthicsHeading","label":"Declarations"}}]}}